- KR₩194bn
- KR₩65bn
- KR₩606bn
- 67
- 89
- 79
- 95
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.75 | ||
| Price to Tang. Book | 0.83 | ||
| Price to Free Cashflow | 10.07 | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | 3.62 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.89% | ||
| Return on Equity | 5.07% | ||
| Operating Margin | 1.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 252,410.79 | 260,417.43 | 274,579.53 | 610,731.08 | 606,281.89 | n/a | n/a | 17.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -29.88 | +32.55 | -42.27 | -2.87 | +5.07 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HDC Labs Co Ltd, formerly HDC I-Controls Co Ltd, is a Korea-based company mainly engaged in the provision of information technology (IT) consulting services for the construction industry. The Company operates its business mainly through four segments. The Smart Home segment is mainly engaged in the business of building smart life environment by integrating information technology with the residential environment. The Mechanical and Electrical segment is mainly engaged in business to create an environment required in the production process of residential spaces and industrial facilities. The Smart Building segment is mainly engaged in the business of building systems that control lighting and temperature control, ventilation and communication facilities. The Social Overhead Capital segment is mainly engaged in the business of establishing control systems such as communications and signals in the public sector.
Directors
- Mong Gyu Jung CHM (58)
- Seong Eun Kim CEO (52)
- Hong Gu Lee MDR (57)
- Wuk Hyeon Cho OTH (59)
- Gwang Seon Gwak OTH (57)
- Chang Wu Lee DRC (62)
- Jin Oh Kim NID (56)
- Seong Hwan Lee NID (53)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 17th, 1999
- Public Since
- September 24th, 2015
- No. of Shareholders
- 4,804
- No. of Employees
- 192
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Korea Exchange - KSE- Shares in Issue
- 22,974,436
- Address
- Seocho HDC Labs Tower, SEOUL, 06722
- Web
- http://www.hdc-icontrols.com/
- Phone
- +82 218991909
- Auditors
- Samil Accounting Corporation
Upcoming Events for 039570
Q2 2024 HDC Labs Co Ltd Earnings Release
Similar to 039570
Asiana IDT
Korea Exchange - KSE
CItech Co
Korea Exchange - KSE
Comtec Systems Co
Korea Exchange - KSE
DB
Korea Exchange - KSE
Doubleu Games Co
Korea Exchange - KSE
FAQ
What is the HDC Labs Co share price?
As of Today at 19:10 UTC, shares in HDC Labs Co are trading at KR₩8,440. This share price information is delayed by 15 minutes.
How has the HDC Labs Co share price performed this year?
Shares in HDC Labs Co last closed at KR₩8,440 and the price had moved by +7.19% over the past 365 days. In terms of relative price strength the HDC Labs Co share price has outperformed the FTSE Developed Asia Pacific Index by +7.93% over the past year.
What are the analyst and broker recommendations for HDC Labs Co?
The overall consensus recommendation for HDC Labs Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the HDC Labs Co dividend yield?
The HDC Labs Co dividend yield is 5.33% based on the trailing twelve month period.
Does HDC Labs Co pay a dividend?
Last year, HDC Labs Co paid a total dividend of KR₩450, and it currently has a trailing dividend yield of 5.33%.Looking ahead, the next dividend pay date is 2024-04-25.
When does HDC Labs Co next pay dividends?
We do not have data on when HDC Labs Co is to next pay dividends. The historic dividend yield on HDC Labs Co shares is currently 5.33%.
How do I buy HDC Labs Co shares?
To buy shares in HDC Labs Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HDC Labs Co?
As of the previous close price of KR₩8,440, shares in HDC Labs Co had a market capitalisation of KR₩194bn.
Where are HDC Labs Co shares listed?
Here are the trading details for HDC Labs Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 039570
What kind of share is HDC Labs Co?
Based on an overall assessment of its quality, value and momentum HDC Labs Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HDC Labs Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the HDC Labs Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HDC Labs Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +2.09%.
As of the last closing price of KR₩8,440, shares in HDC Labs Co were trading +8.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HDC Labs Co PE Ratio?
The HDC Labs Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩8,440.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HDC Labs Co?
HDC Labs Co's management team is headed by:
- Mong Gyu Jung - CHM
- Seong Eun Kim - CEO
- Hong Gu Lee - MDR
- Wuk Hyeon Cho - OTH
- Gwang Seon Gwak - OTH
- Chang Wu Lee - DRC
- Jin Oh Kim - NID
- Seong Hwan Lee - NID